Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer.
Humbert O, Bauckneht M, Gal J, Paquet M, Chardin D, Rener D, Schiazza A, Genova C, Schiappa R, Zullo L, Rossi G, Martin N, Hugonnet F, Darcourt J, Morbelli S, Otto J. Humbert O, et al. Among authors: hugonnet f. Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3878-3891. doi: 10.1007/s00259-022-05788-8. Epub 2022 May 14. Eur J Nucl Med Mol Imaging. 2022. PMID: 35562529 Free PMC article.
Metastatic renal cell carcinoma: relationship between initial metastasis hypoxia, change after 1 month's sunitinib, and therapeutic response: an 18F-fluoromisonidazole PET/CT study.
Hugonnet F, Fournier L, Medioni J, Smadja C, Hindié E, Huchet V, Itti E, Cuenod CA, Chatellier G, Oudard S, Faraggi M; Hypoxia in Renal Cancer Multicenter Group. Hugonnet F, et al. J Nucl Med. 2011 Jul;52(7):1048-55. doi: 10.2967/jnumed.110.084517. Epub 2011 Jun 16. J Nucl Med. 2011. PMID: 21680694 Free article. Clinical Trial.
COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome.
Dietz M, Chironi G, Claessens YE, Farhad RL, Rouquette I, Serrano B, Nataf V, Hugonnet F, Paulmier B, Berthier F, Keita-Perse O, Giammarile F, Perrin C, Faraggi M; MONACOVID Group. Dietz M, et al. Among authors: hugonnet f. Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):260-268. doi: 10.1007/s00259-020-04968-8. Epub 2020 Jul 25. Eur J Nucl Med Mol Imaging. 2021. PMID: 32712702 Free PMC article. Clinical Trial.
Role of positron emission tomography (PET) in head and neck cancer.
Duet M, Hugonnet F, Faraggi M. Duet M, et al. Among authors: hugonnet f. Eur Ann Otorhinolaryngol Head Neck Dis. 2010 Mar;127(1):40-5. doi: 10.1016/j.anorl.2010.02.010. Epub 2010 Mar 25. Eur Ann Otorhinolaryngol Head Neck Dis. 2010. PMID: 20822756 Free article. Review.
Differences in the biologic activity of 2 novel MEK inhibitors revealed by 18F-FDG PET: analysis of imaging data from 2 phase I trials.
Kraeber-Bodéré F, Carlier T, Naegelen VM, Shochat E, Lumbroso J, Trampal C, Nagarajah J, Chua S, Hugonnet F, Stokkel M, Gleeson F, Tessier J. Kraeber-Bodéré F, et al. Among authors: hugonnet f. J Nucl Med. 2012 Dec;53(12):1836-46. doi: 10.2967/jnumed.112.109421. Epub 2012 Nov 9. J Nucl Med. 2012. PMID: 23143089 Free article.
16 results